
Marsh McLennanMRSH
The latest on Marsh McLennan
Our stories first, then the headlines that could move it, newest first.
We haven't written about Marsh McLennan yet. Follow it, and its first story will show under My stocks.
Quality and valuation
How Marsh McLennan compares with other financials stocks. A description, not a recommendation.
AJG
AON
WTW
BRO
ERIE
MRSHMarsh McLennan and 5 insurance brokers peers. Across: valuation (P/E) against the sector. Up: business quality against the sector. Hover or tap a logo for its numbers.
An average business among financials companies, priced above most of them.
Marsh McLennan trades at 18.2 times the next 12 months of expected earnings, against a median of 13.0x for the 84 financials stocks we cover. The quality score blends where it ranks on revenue growth, gross margin, operating margin and free-cash-flow margin (net margin for banks and insurers) over the last 12 months, from SEC filings.
- Revenue grew slower than the sector median: +7.6% vs +10.2%
- Less profitable (operating margin): 21.4% vs 22.3%
- Turns less of its sales into cash: 14.6% vs 20.3%
Financials
From Marsh McLennan's SEC filings, through the quarter ending 30 Sep 2026. Hover or tap a bar for its value.
| Last 12 months | MRSH | Sector median |
|---|---|---|
| Revenue growth | +7.6% | +10.2% |
| Operating margin | 21.4% | 22.3% |
| Free cash flow margin | 14.6% | 20.3% |
| Price to earnings | 24.1x | 14.6x |
Similar companies
Insurance Brokers, by market value.
| Company | Price | Today |
|---|---|---|
AJGArthur J. Gallagher | $276.07 | +2.93% |
AONAon | $321.67 | +0.01% |
WTWWillis Towers Watson | $324.42 | +1.15% |
BROBrown & Brown | $69.76 | +2.83% |
ERIEErie Indemnity | $261.39 | +4.23% |